首页> 外文会议>Bioinformatics and Biomedical Engineering , 2009. ICBBE 2009 >Sustained-Release Floating Drug Delivery Systems Prepared Using Three-Dimensional Printing
【24h】

Sustained-Release Floating Drug Delivery Systems Prepared Using Three-Dimensional Printing

机译:使用三维印刷制备的缓释漂浮药物递送系统

获取原文

摘要

Sustained-release floating drug delivery systems (FDDSs) enable prolonged and continuous input of the drug to the upper parts of the gastrointestinal tract have been designed and fabricated using three dimensional printing (3DP) technology. A new strategy is proposed for the development of FDDSs. The design of FDDSs was based on the sustained release formulation, with low density and floating features in order to prolong the gastric retention time, with special surface textures and variations of drug distribution in the FDDSs for constant release profiles. The local variations of drug in the FDDSs were traced by methylene blue. To measure the floating force, a novel apparatus was developed. Duration of buoyancy and drug release profiles were determined in vitro. It was found that FDDSs were able to float on the dissolution medium 12h, which was the whole tests time periods, and free out the model drug metformin hydrochloride in a way of near zero-order kinetics. 3DP is able to offer possibility for developing FDDSs with complicated design features for providing long-time gastro-retention and desired drug release profiles.
机译:使用三维打印(3DP)技术设计和制造了持续释放的浮动药物输送系统(FDDSs),可以将药物长期和连续地输入到胃肠道的上部。提出了开发FDDS的新策略。 FDDS的设计基于缓释制剂,具有低密度和漂浮特性,从而延长了胃的保留时间,并具有特殊的表面质地和FDDS中药物分布的变化,以实现恒定释放。 FDDS中药物的局部变化由亚甲基蓝追踪。为了测量浮力,开发了一种新颖的设备。在体外确定浮力的持续时间和药物释放曲线。发现FDDS能够漂浮在整个测试时间段的溶解介质12h上,并以接近零级动力学的方式释放出模型药物盐酸二甲双胍。 3DP能够为开发具有复杂设计特征的FDDS提供可能性,以提供长期的胃内滞留和所需的药物释放曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号